DoW Reconstructive Transplant, Investigator-Initiated Research Award
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The fiscal year 2026 Reconstructive Transplant Research Program Investigator-Initiated Research Award, solicitation number HT942526RTRPIIRA, provides funding for studies aimed at improving reconstructive transplant research, patient care, and quality of life. Managed by the Defense Health Agency Contracting Activity under the Department of Defense, the program supports a broad scope of research ranging from basic and preclinical animal models to clinical research in human subjects, though it explicitly excludes clinical trials. All proposals must align with FY26 RTRP Focus Areas and demonstrate military-relevant utility by addressing the healthcare needs of Service Members, Veterans, and their families. Applicants are required to provide preliminary or published data to support their research rationale and must implement a rigorous study design with a strong statistical plan to ensure reproducibility and translational feasibility. The deadline for responses is November 4, 2026. While collaboration with military researchers and clinicians is encouraged, it is not a mandatory requirement for submission.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Summary: The fiscal year 2026 (FY26) Reconstructive Transplant Research Program (RTRP) Investigator-Initiated Research Award supports studies that have the potential to make an important contribution to reconstructive transplant research, patient care, and/or quality of life. All projects must demonstrate solid scientific rationale with military-relevant utility. The Investigator-Initiated Research Award does not support clinical trials.
Distinctive Features:
· Scope: Applications may focus on any phase of research from basic through translational, including preclinical studies in animal models, and clinical research in human subjects or human anatomical substances.
· Study Design and Feasibility: The study design should be rigorous and support maximal reproducibility and translational feasibility. A strong statistical plan with appropriate power analysis is important.
· Impact: Project results should have the potential for long- and short-term impact on the reconstructive transplant research field and/or patient community. Projects should address at least one of the FY26 RTRP Focus Areas.
· Preliminary Data: Preliminary and/or published data that are relevant to reconstructive transplantation and support the rationale for the proposed research must be included.
· Military Relevance: All projects must be responsive to the health care needs of military Service Members and/or Veterans recovering from traumatic injury, and/or their Family members, caregivers, or clinicians, as well as the general public. Collaboration with military researchers and clinicians is encouraged but not required.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca
Same awarding agency
